Healthcare
Saudi Arabia announces AI-powered diabetic-retinopathy screening
Saudi Arabia introduced AI-powered eye-screening tests designed to support diabetic-retinopathy diagnosis while reducing screening time and costs.
Saudi Arabia announced AI-powered eye-screening tests capable of supporting diagnosis of diabetic retinopathy. The initiative is presented as a way to simplify screening while reducing the time and cost associated with conventional diagnostic processes. Diabetic retinopathy is a major complication of diabetes, and earlier identification can support timely clinical management. The development forms part of a broader pattern of AI adoption in Saudi healthcare, where automated analysis is being applied to screening and diagnostic workflows. The practical value lies in potentially expanding access to eye examinations and helping healthcare providers process more patients efficiently. Automated screening can also support consistency by applying the same analysis across large numbers of retinal images, while clinicians retain responsibility for diagnosis and treatment decisions. The announcement signals continued movement toward AI-enabled preventive care in Saudi Arabia, particularly in areas where population-wide screening is operationally demanding. It also highlights how computer vision is becoming a practical healthcare application rather than only an experimental technology.
Original source: BioSpectrum Asia